Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus.

Aoki TT, Benbarka MM, Okimura MC, Arcangeli MA, Walter RM Jr, Wilson LD, Truong MP, Barber AR, Kumagai LF.

Lancet. 1993 Aug 28;342(8870):515-8.

PMID:
8102666
2.
3.

Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG.

Diabetes Care. 1997 Jan;20(1):59-63.

PMID:
9028695
5.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081. Epub 2011 Jul 13.

PMID:
21751889
6.

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

Schnell O, Eisfelder B, Standl E, Ziegler AG.

Diabetes. 1997 Oct;46(10):1607-11.

PMID:
9313757
7.

A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.

Guelho D, Paiva I, Batista C, Barros L, Carrilho F.

Minerva Endocrinol. 2014 Jun;39(2):127-33.

PMID:
24736487
8.

Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.

Tsui EY, Chiasson JL, Tildesley H, Barnie A, Simkins S, Strack T, Zinman B.

Diabetes Care. 1998 Jan;21(1):93-6.

PMID:
9538976
9.

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

Diabetes Care. 1998 Oct;21(10):1627-31.

PMID:
9773721
10.
11.

Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.

Katsura M, Kawamori R, Yamasaki Y, Iwama N, Kubota M, Goriya Y, Kajimoto Y, Shichiri M, Kamada T.

Diabetes Res Clin Pract. 1993 May;20(2):93-100.

PMID:
8375272
13.

Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.

Hanas R, Adolfsson P.

Pediatr Diabetes. 2006 Feb;7(1):25-31. Erratum in: Pediatr Diabetes. 2006 Oct;7(5):298.

PMID:
16489971
14.

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

Diabetes Care. 2002 Nov;25(11):2074-80.

PMID:
12401759
15.

Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.

Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L.

Pediatr Diabetes. 2009 Aug;10(5):298-303. doi: 10.1111/j.1399-5448.2008.00471.x. Epub 2008 Oct 20.

PMID:
19175902
16.

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

Diabetes Care. 1995 Nov;18(11):1452-9.

PMID:
8722069
17.

Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM.

Hoffman RP, Singer-Granick C, Drash AL, Becker DJ.

Diabetes Care. 1991 Feb;14(2):81-8.

PMID:
2060427
18.

Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.

Willi SM, Planton J, Egede L, Schwarz S.

J Pediatr. 2003 Dec;143(6):796-801.

PMID:
14657831
19.

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.

Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH.

Diabetes Care. 1997 Dec;20(12):1827-32.

PMID:
9405901
20.

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.

PMID:
18502299

Supplemental Content

Support Center